Medical Review Officer Services
Medical Review Officer (MRO) services are available for interpretation of drug test results. The MRO is a licensed physician who is certified by the American Association of Medical Review Officers and knowledgeable in the medical use of prescription drugs and the pharmacology and toxicology of Illicit drugs. For all positive test results the MRO will conduct a medical interview by phone or in person, including review of medical history or any relevant biomedical factors, prior to reporting a positive result to the Company. The MRO will advise the individual of the right to have the secondary split specimen tested if the request is made within 72 hours of the notification of a verified positive result.
If the MRO is unable to reach the individual who has tested positive after three attempts over a twenty-four hour period, the MRO will notify the Company via the designated employer representative and request the Company ask the individual to contact the MRO.
UHS News
-
Large turnout as Team UHS shows support at annual "Making Strides" walkOctober 13, 2025Many UHS staff members turned out October 12 for the 2025 edition of the “Making Strides Against Breast Cancer” walk at Mirabito Stadium in Binghamton.
-
Consider early detection this Breast Cancer Awareness MonthOctober 13, 2025October is Breast Cancer Awareness Month, an annual campaign to educate the community on the prevalence of breast cancer, the importance of scheduling mammograms, and the lasting impact of a breast cancer diagnosis. For one breast cancer patient, a routine mammogram made all the difference.
-
UHS Delaware Valley Hospital receives early intervention approvalOctober 10, 2025The UHS Delaware Valley Hospital (UHS-DVH) therapy department has been officially approved by New York State to offer speech and occupational therapy services through the Early Intervention Program (EIP).
-
UHS named 2025 winner in Survale Candidate Experience Benchmark Research and Awards ProgramOctober 08, 2025UHS is proud to be named one of the 66 global CandE-winning companies with near and above benchmark average ratings in this year’s CandE Benchmark Research Program!
